CLOV vs INNV
CLOV: Clover Health combines Medicare Advantage insurance with a proprietary, AI-driven clinical decision-support platform designed to improve health outcomes and manage costs for Medicare beneficiaries. INNV: InnovAge operates integrated primary care and chronic disease management centers under the PACE model for frail elderly populations, earning capitated fees from government payors.
Side-by-side fundamentals
| Metric | CLOV | INNV | Edge |
|---|---|---|---|
| Price as of 2026-07-27 close | $4.27 | $11.60 | |
| Market cap as of 2026-07-31 | $2.3B | $1.6B | |
| PEG as of 2026-07-31 | -0.31 | n/a | |
| Net margin as of 2026-07-31 | -2.6% | -1.2% | INNV higher |
| Gross margin as of 2026-07-31 | n/a | +21.8% | |
| Operating margin as of 2026-07-31 | -2.6% | -1.0% | INNV higher |
| ROE as of 2026-07-31 | -17.1% | -4.8% | INNV higher |
| ROA as of 2026-07-31 | -9.6% | -2.2% | INNV higher |
| Debt / equity as of 2026-07-31 | 0.00 | 0.30 | CLOV lower |
| Revenue growth (YoY) as of 2026-07-31 | +48.8% | +14.1% | CLOV higher |
| Revenue CAGR (3y) SEC XBRL | +20.6% | +6.9% | CLOV higher |
| Beta as of 2026-07-31 | 2.53 | 1.14 | |
| 1-year return as of 2026-07-27 close | +40.7% | +226.8% | INNV higher |
Fundamentals: market data, as of 2026-07-31. Filings: SEC EDGAR. Prices are delayed daily-close data.
Last updated 2026-07-27.
Informational only — NOT financial advice. All figures are delayed daily-close data from SEC EDGAR & market data, shown with their as-of date; "Edge" cells are a pure numeric comparison, not a recommendation.